Clostridioides difficile - Revision history

Prab at 15:20, 1 April 2025

2025-04-01T15:20:38Z

← Older revision		Revision as of 15:20, 1 April 2025
Line 1:		Line 1:
	'''Clostridioides difficile''' ('''C. difficile''', formerly known as ''Clostridium difficile'') is a [[Gram-positive bacteria\|Gram-positive]], [[spore]]-forming, [[anaerobic bacteria]] that can cause severe [[infection]]s in the human [[gastrointestinal system]]. C. difficile is the most common cause of healthcare-associated [[diarrhea]] and can lead to life-threatening [[colitis]] in severe cases.~~<ref>{{Cite web\|title = Clostridioides difficile Infection\|url = https://www.cdc.gov/cdiff/\|website = Centers for Disease Control and Prevention\|access-date = 2023-05-05}}</ref>~~		'''Clostridioides difficile''' ('''C. difficile''', formerly known as ''Clostridium difficile'') is a [[Gram-positive bacteria\|Gram-positive]], [[spore]]-forming, [[anaerobic bacteria]] that can cause severe [[infection]]s in the human [[gastrointestinal system]]. C. difficile is the most common cause of healthcare-associated [[diarrhea]] and can lead to life-threatening [[colitis]] in severe cases.
	[[File:23247 lores.jpg\|thumb\|23247 lores]][[File:Pseudomembranoese Colitis Endo1.jpg\|thumb\|Pseudomembranoese Colitis Endo1]]		[[File:23247 lores.jpg\|thumb\|23247 lores]][[File:Pseudomembranoese Colitis Endo1.jpg\|thumb\|Pseudomembranoese Colitis Endo1]]
	== Epidemiology ==		== Epidemiology ==
	C. difficile infections (CDIs) are responsible for significant morbidity and mortality, particularly in healthcare settings such as [[hospital]]s and [[long-term care facility\|long-term care facilities]]. The incidence of CDI has increased over the past few decades, with elderly patients and those with compromised immune systems being at the highest risk.<ref>{{Cite journal\|title = Clostridium difficile infection: A review of current and emerging therapies\|journal = Annals of Gastroenterology\|volume = 29\|issue = 2\|pages = 147-154\|year = 2016\|author = Peniche, A. G., Savidge, T. C., & Dann, S. M.\|url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808106/}}</ref>		C. difficile infections (CDIs) are responsible for significant morbidity and mortality, particularly in healthcare settings such as [[hospital]]s and [[long-term care facility\|long-term care facilities]]. The incidence of CDI has increased over the past few decades, with elderly patients and those with compromised immune systems being at the highest risk.

	== Pathogenesis ==		== Pathogenesis ==
	C. difficile produces two primary toxins, toxin A and toxin B, which cause inflammation and damage to the [[intestinal mucosa]]. The bacteria can form spores that are resistant to environmental conditions and are easily transmitted between individuals. CDI typically occurs when the normal [[gut flora]] is disrupted, often due to [[antibiotic]] use, which allows C. difficile to proliferate and produce toxins.<ref>{{Cite journal\|title = Clostridium difficile Infection: An Overview of the Disease and Its Pathogenesis, Epidemiology and Interventions\|journal = Gut Microbes\|volume = 1\|issue = 4\|pages = 234-242\|year = 2010\|author = Rupnik, M., Wilcox, M. H., & Gerding, D. N.\|url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056111/}}</ref>		C. difficile produces two primary toxins, toxin A and toxin B, which cause inflammation and damage to the [[intestinal mucosa]]. The bacteria can form spores that are resistant to environmental conditions and are easily transmitted between individuals. CDI typically occurs when the normal [[gut flora]] is disrupted, often due to [[antibiotic]] use, which allows C. difficile to proliferate and produce toxins.

	== Clinical manifestations ==		== Clinical manifestations ==
	Symptoms of CDI can range from mild diarrhea to severe colitis, [[toxic megacolon]], and even death. Common symptoms include:		Symptoms of CDI can range from mild diarrhea to severe colitis, [[toxic megacolon]], and even death. Common symptoms include:

	Watery diarrhea (occurring at least three times per day for two or more days)		* Watery diarrhea (occurring at least three times per day for two or more days)
	Abdominal pain or cramping		* Abdominal pain or cramping
	Fever		* Fever
	Loss of appetite		* Loss of appetite
	Nausea		* Nausea
	Dehydration<ref>{{Cite web\|title = Symptoms & Causes of C. difficile\|url = https://www.niddk.nih.gov/health-information/digestive-diseases/c-difficile/symptoms-causes\|website = National Institute of Diabetes and Digestive and Kidney Diseases\|access-date = 2023-05-05}}</ref>		* Dehydration
	== Diagnosis ==		== Diagnosis ==
	Diagnosis of CDI typically involves stool testing for the presence of C. difficile toxins or the bacteria itself. Additional tests may include [[endoscopy]] or [[imaging]] studies, such as abdominal [[computed tomography]] (CT) scans, to assess the severity of the infection and potential complications.<ref>{{Cite web\|title = Diagnosis of C. difficile\|url = https://www.niddk.nih.gov/health-information/digestive-diseases/c-difficile/diagnosis\|website = National Institute of Diabetes and Digestive and Kidney Diseases\|access-date = 2023-05-05}}</ref>		Diagnosis of CDI typically involves stool testing for the presence of C. difficile toxins or the bacteria itself. Additional tests may include [[endoscopy]] or [[imaging]] studies, such as abdominal [[computed tomography]] (CT) scans, to assess the severity of the infection and potential complications.

	== Treatment ==		== Treatment ==
	The primary treatment for CDI includes the discontinuation of the inciting antibiotic (if possible) and the initiation of a targeted antibiotic regimen, such as [[metronidazole]], [[vancomycin]], or [[fidaxomicin]].<ref>{{Cite journal\|title = Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)\|journal = Clinical Infectious Diseases\|volume = 66\|issue = 7\|pages = e1-e48\|year = 2018\|author = McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., ... & Wilcox, M. H.\|url = https://academic.oup.com/cid/article/66/7/e1/4855916}}</ref> In severe or recurrent cases, [[fecal microbiota transplantation]] (FMT) may be considered to restore the normal gut flora and prevent further CDI recurrence.<ref>{{Cite journal\|title = Fecal microbiota transplantation for recurrent Clostridium difficile infection\|journal = Journal of Clinical Gastroenterology\|volume = 48\|issue = 3\|pages = 241-247\|year = 2014\|author = Gough, E., Shaikh, H., & Manges, A. R.\|url = https://www.ncbi.nlm.nih.gov/pubmed/24172179}}</ref>		The primary treatment for CDI includes the discontinuation of the inciting antibiotic (if possible) and the initiation of a targeted antibiotic regimen, such as [[metronidazole]], [[vancomycin]], or [[fidaxomicin]].

	== Prevention ==		== Prevention ==
Line 26:		Line 26:

	== See also ==		== See also ==
			* [[Antibiotic-associated diarrhea]]
	[[Antibiotic-associated diarrhea]]		* [[Infection control]]
	[[Infection control]]		* [[Probiotics]]
	[[Probiotics]]		* [[Pseudomembranous colitis]]
	[[Pseudomembranous colitis]]
	~~== References ==~~

	~~{{Reflist}}~~

	~~{{stub}}~~

	[[Category:Bacteria]]		[[Category:Bacteria]]
	[[Category:Gastrointestinal disorders]]		[[Category:Gastrointestinal disorders]]
	[[Category:Infectious diseases]]{{stub}}		[[Category:Infectious diseases]]{{stub}}

Prab at 00:41, 7 May 2023

2023-05-07T00:41:06Z

New page

'''Clostridioides difficile''' ('''C. difficile''', formerly known as ''Clostridium difficile'') is a [[Gram-positive bacteria|Gram-positive]], [[spore]]-forming, [[anaerobic bacteria]] that can cause severe [[infection]]s in the human [[gastrointestinal system]]. C. difficile is the most common cause of healthcare-associated [[diarrhea]] and can lead to life-threatening [[colitis]] in severe cases.<ref>{{Cite web|title = Clostridioides difficile Infection|url = https://www.cdc.gov/cdiff/|website = Centers for Disease Control and Prevention|access-date = 2023-05-05}}</ref>
[[File:23247 lores.jpg|thumb|23247 lores]][[File:Pseudomembranoese Colitis Endo1.jpg|thumb|Pseudomembranoese Colitis Endo1]]
== Epidemiology ==
C. difficile infections (CDIs) are responsible for significant morbidity and mortality, particularly in healthcare settings such as [[hospital]]s and [[long-term care facility|long-term care facilities]]. The incidence of CDI has increased over the past few decades, with elderly patients and those with compromised immune systems being at the highest risk.<ref>{{Cite journal|title = Clostridium difficile infection: A review of current and emerging therapies|journal = Annals of Gastroenterology|volume = 29|issue = 2|pages = 147-154|year = 2016|author = Peniche, A. G., Savidge, T. C., & Dann, S. M.|url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808106/}}</ref>

== Pathogenesis ==
C. difficile produces two primary toxins, toxin A and toxin B, which cause inflammation and damage to the [[intestinal mucosa]]. The bacteria can form spores that are resistant to environmental conditions and are easily transmitted between individuals. CDI typically occurs when the normal [[gut flora]] is disrupted, often due to [[antibiotic]] use, which allows C. difficile to proliferate and produce toxins.<ref>{{Cite journal|title = Clostridium difficile Infection: An Overview of the Disease and Its Pathogenesis, Epidemiology and Interventions|journal = Gut Microbes|volume = 1|issue = 4|pages = 234-242|year = 2010|author = Rupnik, M., Wilcox, M. H., & Gerding, D. N.|url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056111/}}</ref>

== Clinical manifestations ==
Symptoms of CDI can range from mild diarrhea to severe colitis, [[toxic megacolon]], and even death. Common symptoms include:

Watery diarrhea (occurring at least three times per day for two or more days)
Abdominal pain or cramping
Fever
Loss of appetite
Nausea
Dehydration<ref>{{Cite web|title = Symptoms & Causes of C. difficile|url = https://www.niddk.nih.gov/health-information/digestive-diseases/c-difficile/symptoms-causes|website = National Institute of Diabetes and Digestive and Kidney Diseases|access-date = 2023-05-05}}</ref>
== Diagnosis ==
Diagnosis of CDI typically involves stool testing for the presence of C. difficile toxins or the bacteria itself. Additional tests may include [[endoscopy]] or [[imaging]] studies, such as abdominal [[computed tomography]] (CT) scans, to assess the severity of the infection and potential complications.<ref>{{Cite web|title = Diagnosis of C. difficile|url = https://www.niddk.nih.gov/health-information/digestive-diseases/c-difficile/diagnosis|website = National Institute of Diabetes and Digestive and Kidney Diseases|access-date = 2023-05-05}}</ref>

== Treatment ==
The primary treatment for CDI includes the discontinuation of the inciting antibiotic (if possible) and the initiation of a targeted antibiotic regimen, such as [[metronidazole]], [[vancomycin]], or [[fidaxomicin]].<ref>{{Cite journal|title = Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)|journal = Clinical Infectious Diseases|volume = 66|issue = 7|pages = e1-e48|year = 2018|author = McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., ... & Wilcox, M. H.|url = https://academic.oup.com/cid/article/66/7/e1/4855916}}</ref> In severe or recurrent cases, [[fecal microbiota transplantation]] (FMT) may be considered to restore the normal gut flora and prevent further CDI recurrence.<ref>{{Cite journal|title = Fecal microbiota transplantation for recurrent Clostridium difficile infection|journal = Journal of Clinical Gastroenterology|volume = 48|issue = 3|pages = 241-247|year = 2014|author = Gough, E., Shaikh, H., & Manges, A. R.|url = https://www.ncbi.nlm.nih.gov/pubmed/24172179}}</ref>

== Prevention ==
Preventing the spread of C. difficile involves implementing strict infection control measures, such as hand hygiene, contact precautions, and environmental cleaning. In addition, judicious use of antibiotics is crucial in reducing the risk of CDI.<ref>{{Cite web|title = Prevention of C. difficile|url = https://www.niddk.nih.gov/health-information/digestive-diseases/c-difficile/prevention|website = National Institute of Diabetes and Digestive and Kidney Diseases|access-date = 2023-05-05}}</ref>

== See also ==

[[Antibiotic-associated diarrhea]]
[[Infection control]]
[[Probiotics]]
[[Pseudomembranous colitis]]
== References ==

{{Reflist}}

{{stub}}

[[Category:Bacteria]]
[[Category:Gastrointestinal disorders]]
[[Category:Infectious diseases]]{{stub}}